ReGen Biologics, Inc. Files for Bankruptcy

Published: Apr 12, 2011

Mass Device -- Embattled ReGen Biologics Inc. files voluntary petitions for Chapter 11 bankruptcy protection and announces a $1 million private placement from one of its largest investors. FDA, ReGen Biologics

ReGen Biologics Inc. filed for Chapter 11 bankruptcy protection with the U.S. Bankruptcy Court for the District of Delaware.

Back to news